Yale Cardiovascular Research Group
Yale Cardiovascular Research Group
Explore linked clinical trials.11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial) | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2026-08-27 | NCT06321575 | |
| Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Femoral Stenting (SKYWARD Trans-Femoral IDE [Investigational Device Exemption] Study) | Nutritional and Metabolic Diseases, brain disorder, calcinosis, calcium metabolic disease, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebrovascular disorder, metabolic disease, nervous system disorder, vascular disorder | Not yet recruiting | Not applicable | 2026-07-31 | NCT07512128 | |
| Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study) | Nutritional and Metabolic Diseases, brain disorder, calcinosis, calcium metabolic disease, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebrovascular disorder, metabolic disease, nervous system disorder, vascular disorder | Recruiting | Not applicable | 2026-07-31 | NCT07062471 | |
| Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Not yet recruiting | Not applicable | 2026-05-08 | NCT07575568 | |
| Serranator POINT FORCE Registry | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not stated | 2026-05-07 | NCT06687590 | |
| The CONFORMAL Early Feasibility Study | Non-valvular Atrial Fibrillation | Active, not recruiting | Not applicable | 2026-02-13 | NCT03616028 | |
| Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR | aortic valve disorder, aortic valve insufficiency, cardiovascular disorder, heart disorder, heart valve disorder | Not yet recruiting | Not applicable | 2025-08-19 | NCT07129421 | |
| Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve insufficiency, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2025-08-06 | NCT05295628 | |
| Encore PFO Closure Device - The PerFOrm Trial | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryptogenic Ischemic Stroke, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, ischemic stroke, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorder | Recruiting | Not applicable | 2024-09-19 | NCT05537753 | |
| Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System | Arterial Occlusive Diseases, brain disorder, cardiovascular disorder, carotid artery disorder, carotid stenosis, central nervous system disorder, cerebrovascular disorder, nervous system disorder, vascular disorder | Active, not recruiting | Not applicable | 2024-06-06 | NCT04201132 | |
| Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries. | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Not yet recruiting | Not applicable | 2020-09-04 | NCT03423511 |